Huntington's Disease is a rare, fatal, genetic condition that causes the breakdown of nerve cells in the brain over time. As the disease progresses, those afflicted will experience a loss of motor control and cognitive function, with a high percentage eventually losing the ability to speak. With such a terrifying outcome, many at risk choose not to get tested unless they have symptoms. 

​

As Genentech prepared to enter Phase 3 testing for a treatment that had the potential to delay or halt the progression of the disease, there was hope for the first time. This video was part of a campaign pitch aimed at giving those who are at risk renewed hope for treatment as well as encouraging them to get tested. 

​

Client: Genentech via Real Chemistry

​